Canntab Therapeutics

Canntab Therapeutics is an industry leader in solid oral formulations of cannabis, with a product line featuring precise doses of cannabinoids (THC & CBD) and terpene blends. Possessing clear and sustainable competitive advantages, the company has 13 patents pending in Canada and the United States. These patents cover their proprietary processes as well as solid oral dosage forms for extended release, immediate release, fast dissolving, and bilayer medications.